CANS NEWSLETTER—January 2006
1.
CANS—round 1—Board meeting
2. CANS—round 2—Annual meeting
3. CANS—round 3—President’s
Message
4. CANS—round 4—Officers for
2006
1. CANS in
I am always impressed with how much time it takes for volunteer
Boards of Directors of professional organizations to have a meeting.
But if one recognizes that meetings of the board members are where the
work really gets done and the important decisions really made, then the time
spent becomes appropriate, particularly in an organization like CANS with only
three board meetings a year. That
said, the 5-hour board meeting on
Item 1. Our lobbying firm principal,
John Norwood, spoke for about 30
minutes during which time he made a number of points:
1. His organization didn’t do well establishing communication with
CANS.
2. He thinks we are too small to get into the routine lobbying game.
3. He feels the Vargas bill to freeze work comp fees at present levels is
dead
mostly because
of opposition from labor who sees more money for docs as
resulting in
less money for workers; they don’t detect a potential access
problem if our
fees are heavily reduced.
4. He expects the state work comp director to issue a new fee schedule in
the
spring; it will
be an RBRVS system probably at 120% of Medicare rates
which won’t become
effective until late Summer.
5. He thinks the state work comp director reflects the position of the
admin-
istration,
cannot be lobbied and our only hope to improve # 4 (above) is to get our
position on a better
deal (see Item 2) directly before the Governor through
some special contact
person which he doesn’t have.
Following his presentation, the board voted to terminate our contract with him. President Edwards then named an ad hoc committee chaired by Dr. Abou-Samra, our new 1st Vice President, to study how to best employ the lobbying money we now collect as part of the increased dues structure. Report due at the spring board meeting.
Item 2. Steven Levine, M.D., a leader in the Association of California Neurologists, presented his plan to have the new work comp fee schedule be 120% of Medicare but with whatever existing fees that are greater than 120% of Medicare be “grandfathered” to remain at present levels until overtaken by inflation and raises in Medicare rates. He estimates that would put work comp costs at an average of 131.7% of Medicare for now gradually narrowing to 120% over time. He makes a pretty good case for how pushing comp rates to 120% of Medicare or less has created real access problems in other states. The board voted to support his proposal but not fund a focused lobbyist effort to convince the administration to give this plan real consideration. It would seem that this concept needs a buy-in by the Governor that a blanket 120% of Medicare would create access problems. This writer thinks it will because with the discount docs are forced to give to get into Medical Provider Networks, comp fees are likely to be pretty close to Medicare rates and dealing with the comp system for that kind of pay may well discourage at least specialists from participating. There is some thought that the administration and the employer lobby is willing to have access become a problem if not a crisis before giving increased provider pay any consideration.
Item 3. Charles
Bond, an attorney, presented his concept of forming a statewide organization
that would assist neurosurgeons in bargaining with hospitals for ED/Trauma
coverage. Said organization, with
the potential name of California Emergency & Neurosurgical Trauma Services
(CENTS), would conduct an area/regional evaluation of the fair market value of
coverage, then negotiate with hospitals. One
could envision this working in the Los Angeles region where Bill Caton has
cobbled together about 20 like-minded neurosurgeons to cover 9-10 trauma
hospitals (all of which pay some stipend for coverage) and if all those
neurosurgeons were represented by CENTS, the stipends could well be improved
with such a united approach (the anti-trust implication of such a united
approach could be dicey). Just how
CENTS would work in
Item 4. The active members of CANS now number 167, down from 227 this time last year. With the 167 paying $500/year dues, the organization is more solvent than when the 227 were paying $250. No change in dues for active members in 2006.
2.
CANS in
The Saturday morning socioeconomic session was very interesting.
Highlights:
Item 1. Martha
Marsh, CEO of Stanford Hospitals and Clinics, presented data indicating
neurosurgeons continue to be the specialty that brings in the most profit for
hospitals, although her data from 2003 is a bit dated.
She reported that their Trauma service is profitable.
Item 3. John Kusske reiterated that the EMTALA law does mandate that if you are the neurosurgeon named as covering a hospital’s ED and your hospital has a bed, you must accept a patient referred from another institution if they declare themselves unable to provide emergency neurosurgical care. This is apparently becoming an increasingly difficult avenue for referring hospitals with marginal or no neurosurgical coverage to pursue as receiving hospitals with 24/7 neurosurgical coverage are frequently full, requiring the referring hospital to shop far and wide to unload the patient.
Item 4. The
morning “
The panel discussion among the directors of
CANS wishes to acknowledge and thank the following companies who either exhibited or provided grants to defray some of the costs associated with the meeting: Aloka Ultrasound, Anspach Companies, Baxter Healthcare, BrainLab, Endius, I-Flow, KLS-Martin, Medtronic, PDL BioPharma, Porex Surgical, Radionics, Synergy Medical, Synthes, TrueMRI and UCB Pharma.
3. CANS—Message
from the President: Transitions
in Neurosurgery
January is the traditional month at our annual meeting when the
changing of the guard occurs in CANS. I
am honored to be the 32nd President of CANS, and look forward to interacting, as
much as possible, with all of you. I
would like to thank Mike Edwards for leading us so capably the last year, and
hope to impose on his experience and advice over this coming year.
I must admit that I am very proud to be a neurological surgeon and I very much enjoyed active practice. My current activity as a Medical Consultant to the State of California is certainly less demanding and less interesting, but I still consider myself to be a neurosurgeon and I intend to stay active in our specialty.
Prior to the present newsletter editor, Randy Smith, I occupied that slot and contributed, at intervals, articles entitled “Transitions in Neurosurgery” which I intend to continue this year as President of CANS. We are fortunate that Randy Smith has agreed to continue as newsletter editor. I am grateful to him for this and we all recognize his characteristic style.
I hope to represent our profession and organization well, and am receptive to your comments and suggestions. I shall attempt to increase our membership numbers and leave an even stronger organization to the next President.
Many do not realize how fortunate we are to have such a
competent and valued executive secretary in our CANS office, Janine Tash.
Our efforts and successes that may occur are greatly facilitated by her
talents and dedication to our organization.
Working with her is a pleasure.
John Bonner, M.D., F.A.C.S.
4.
CANS Officers for 2006
John
T. Bonner, MD, President,
559 431-1284 (home), 559
440-5081(work), rbonnerns@earthlink.net
Patrick J. Wade, MD, President Elect,
818 247-0888,
pjw7@earthlink.net
Moustapha
Abou-Samra, MD, 1st Vice President,
805 643-2179,
mabousamra@aol.com
William L. Caton III, MD,
2nd Vice President,
626 793-8194 ,
wlciiimd@earthlink.net
Marc A. Vanefsky, MD, Secretary,
714 279-4958, marc.a.vanefsky@kp.org
Michael H. Robbins, MD, Treasurer,
916 453-0911, mrobbmd@hotmail.com
Michael S. B. Edwards, MD, Immed Past Pres,
650 497-8775,
edwards9@stanford.edu
Alan
T. Hunstock, MD, Past President,
707 523-1873, hunstock@nbna.us
Austin
R. T. Colohan, MD, Director-South,
909 558-4417,
acolohan@ahs.llumc.edu
Eldan Eichbaum, MD, Director-North,
707 523-1873,
eeichbaum@sbcglobal.net
Deborah
C. Henry, MD, Director-South,
714 279-4673,
dchenry.md@sbcglobal.net
J.
Patrick Johnson, MD, Director-South,
310 423-9900,
johnsonjp@cshs.org
Theodore
Kaczmar Jr., MD, Director-North,
831 424-0807,
tedkazz@aol.com
Kenneth Ott, MD, Director-South,
619 297-4481,
kott@cts.com
Kimberly
Page, MD, Director-North, 530 246-2207,
kimberlypage@sbcglobal.net
John
A. Kusske, MD, Consultant, 714 456-6966,
jkusske@uci.edu
Philipp
M. Lippe, MD, Consultant,
408 927-0802, pmlippe@att.net
Donald
J. Prolo, MD, Consultant,
408 295-4022, don@donaldprolo.com
J. Ronald Rich, MD, Consultant, 310 315-3404, bayneurosurg@aol.com
Lawrence
M. Shuer, MD, Consultant, 650 723-6093, lshuer@stanford.edu
Randall
W. Smith, MD, Consultant, 760 741-3809, rws-avopro@sbcglobal.net
The good news is this is a fine set of people to be representing CANS members.
The bad news is that Dr. Bonner has named me Newsletter editor for another year.
Randy Smith, M.D., Editor